Le Lézard
Classified in: Health
Subject: PER

Healogics, Inc. Names David Jollow as Chief Information Security Officer


JACKSONVILLE, Fla., Dec. 14, 2018 /PRNewswire/ -- Healogics, the nation's largest provider of advanced chronic wound care services, today announced that it has appointed David Jollow to serve as Chief Information Security Officer. In this role, Jollow will conduct assessments of current IT security and risks, and provide next generation security solutions. He will also be responsible for enhancing, implementing and operating an updated comprehensive, information security program. Jollow will report to Healogics Chief Information Officer, Ty Smith.

Healogics Chief Information Security Officer, David Jollow

"We are so impressed by David's track record of delivering business value through process excellence and team development," said Smith. "I believe that David's broad experience in establishing, leading and managing information security programs will help us take our offerings to the next level. We are thrilled to welcome him as our new CISO."

Most recently, Jollow served as the Chief Information Security Officer at Nemours Children's Health System for over four years. While there, he developed and led an enterprise information security program. Jollow was also responsible for all aspects of information security including policies and procedures, technology, awareness, training, incident management and team development. Prior to Nemours, Jollow was the head of information security at Bausch & Lomb.

Jollow is a former United States Marine and is a Certified Information Security System Professional (CISSP). He earned his MBA and Bachelor of Science in Electrical Engineering from the Rochester Institute of Technology.

About Healogics
Headquartered in Jacksonville, Fla., Healogics is the nation's wound healing expert. Last year over 330,000 patients received advanced wound care through a nationwide network of nearly 700 Wound Care Centers®. The Healogics team is made up of almost 3,000 employees, 4,000 affiliated physicians and a Healogics Specialty Physician practice group of nearly 300. In addition to the company's network of outpatient Centers, Healogics partners with over 300 skilled nursing facilities to care for patients with chronic wounds, and provides inpatient consults at more than 80 partner hospitals. As the industry leader, Healogics has the largest repository of chronic wound-specific patient data in the country. The Healogics Wound Science Initiative, an effort launched in 2017 to provide peer-reviewed research, recognizes the value and relevance of big data and advanced analytics to drive continuous, collaborative learning towards a better understanding of how to efficiently utilize healthcare resources for patients with wounds. For additional information, please visit Healogics.com.

 

SOURCE Healogics


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: